rs56293913

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000110.4(DPYD):​c.1129-15T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,612,456 control chromosomes in the GnomAD database, including 9,385 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.096 ( 849 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8536 hom. )

Consequence

DPYD
NM_000110.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 1.39

Publications

15 publications found
Variant links:
Genes affected
DPYD (HGNC:3012): (dihydropyrimidine dehydrogenase) The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
DPYD Gene-Disease associations (from GenCC):
  • dihydropyrimidine dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-97573985-A-G is Benign according to our data. Variant chr1-97573985-A-G is described in ClinVar as Benign. ClinVar VariationId is 100103.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.114 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DPYDNM_000110.4 linkc.1129-15T>C intron_variant Intron 10 of 22 ENST00000370192.8 NP_000101.2 Q12882-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DPYDENST00000370192.8 linkc.1129-15T>C intron_variant Intron 10 of 22 1 NM_000110.4 ENSP00000359211.3 Q12882-1

Frequencies

GnomAD3 genomes
AF:
0.0957
AC:
14560
AN:
152086
Hom.:
849
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0589
Gnomad AMI
AF:
0.152
Gnomad AMR
AF:
0.0717
Gnomad ASJ
AF:
0.116
Gnomad EAS
AF:
0.0158
Gnomad SAS
AF:
0.0621
Gnomad FIN
AF:
0.185
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.0989
GnomAD2 exomes
AF:
0.0956
AC:
23775
AN:
248638
AF XY:
0.0987
show subpopulations
Gnomad AFR exome
AF:
0.0582
Gnomad AMR exome
AF:
0.0413
Gnomad ASJ exome
AF:
0.112
Gnomad EAS exome
AF:
0.0155
Gnomad FIN exome
AF:
0.189
Gnomad NFE exome
AF:
0.116
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.103
AC:
150070
AN:
1460252
Hom.:
8536
Cov.:
32
AF XY:
0.103
AC XY:
75163
AN XY:
726364
show subpopulations
African (AFR)
AF:
0.0581
AC:
1943
AN:
33414
American (AMR)
AF:
0.0447
AC:
1990
AN:
44564
Ashkenazi Jewish (ASJ)
AF:
0.110
AC:
2867
AN:
26106
East Asian (EAS)
AF:
0.0174
AC:
689
AN:
39612
South Asian (SAS)
AF:
0.0769
AC:
6626
AN:
86154
European-Finnish (FIN)
AF:
0.184
AC:
9807
AN:
53326
Middle Eastern (MID)
AF:
0.168
AC:
970
AN:
5760
European-Non Finnish (NFE)
AF:
0.107
AC:
119181
AN:
1111008
Other (OTH)
AF:
0.0994
AC:
5997
AN:
60308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
6780
13560
20341
27121
33901
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4112
8224
12336
16448
20560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0957
AC:
14566
AN:
152204
Hom.:
849
Cov.:
32
AF XY:
0.0971
AC XY:
7226
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0590
AC:
2452
AN:
41564
American (AMR)
AF:
0.0716
AC:
1094
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.116
AC:
402
AN:
3464
East Asian (EAS)
AF:
0.0158
AC:
82
AN:
5184
South Asian (SAS)
AF:
0.0618
AC:
298
AN:
4824
European-Finnish (FIN)
AF:
0.185
AC:
1955
AN:
10584
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.116
AC:
7894
AN:
67980
Other (OTH)
AF:
0.0988
AC:
209
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
672
1344
2017
2689
3361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.104
Hom.:
1492
Bravo
AF:
0.0853
Asia WGS
AF:
0.0430
AC:
149
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dihydropyrimidine dehydrogenase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Diasio Lab, Mayo Clinic
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.9
DANN
Benign
0.81
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56293913; hg19: chr1-98039541; COSMIC: COSV64593293; API